» Articles » PMID: 23630356

Reversal of Global CD4+ Subset Dysfunction is Associated with Spontaneous Clinical Resolution of Pulmonary Sarcoidosis

Overview
Journal J Immunol
Date 2013 May 1
PMID 23630356
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcoidosis pathogenesis is characterized by peripheral anergy and an exaggerated, pulmonary CD4(+) Th1 response. In this study, we demonstrate that CD4(+) anergic responses to polyclonal TCR stimulation are present peripherally and within the lungs of sarcoid patients. Consistent with prior observations, spontaneous release of IL-2 was noted in sarcoidosis bronchoalveolar lavage CD4(+) T cells. However, in contrast to spontaneous hyperactive responses reported previously, the cells displayed anergic responses to polyclonal TCR stimulation. The anergic responses correlated with diminished expression of the Src kinase Lck, protein kinase C-θ, and NF-κB, key mediators of IL-2 transcription. Although T regulatory (Treg) cells were increased in sarcoid patients, Treg depletion from the CD4(+) T cell population of sarcoidosis patients did not rescue IL-2 and IFN-γ production, whereas restoration of the IL-2 signaling cascade, via protein kinase C-θ overexpression, did. Furthermore, sarcoidosis Treg cells displayed poor suppressive capacity indicating that T cell dysfunction was a global CD4(+) manifestation. Analyses of patients with spontaneous clinical resolution revealed that restoration of CD4(+) Th1 and Treg cell function was associated with resolution. Conversely, disease progression exhibited decreased Th1 cytokine secretion and proliferative capacity, and reduced Lck expression. These findings implicate normalized CD4(+) T cell function as a potential therapeutic target for sarcoidosis resolution.

Citing Articles

Phenotypes and Endotypes in Sarcoidosis: Unraveling Prognosis and Disease Course.

Papanikolaou I, Chytopoulos K, Kaitatzis D, Kostakis N, Bogiatzis A, Steiropoulos P Biomedicines. 2025; 13(2).

PMID: 40002701 PMC: 11853411. DOI: 10.3390/biomedicines13020287.


Sarcoidosis: molecular mechanisms and therapeutic strategies.

Xu D, Tao X, Fan Y, Teng Y Mol Biomed. 2025; 6(1):6.

PMID: 39904950 PMC: 11794924. DOI: 10.1186/s43556-025-00244-z.


Increased proportions of circulating PD-1 CD4 memory T cells and PD-1 regulatory T cells associate with good response to prednisone in pulmonary sarcoidosis.

Miedema J, de Jong L, Kahlmann V, Bergen I, Broos C, Wijsenbeek M Respir Res. 2024; 25(1):196.

PMID: 38715030 PMC: 11075187. DOI: 10.1186/s12931-024-02833-y.


Coexistent sarcoidosis mimics metastasis in a patient with early-stage non-small cell lung cancer: a case report.

Zhao X, Cheng Y, Wang W Sarcoidosis Vasc Diffuse Lung Dis. 2024; 41(1):e2024008.

PMID: 38567562 PMC: 11008325. DOI: 10.36141/svdld.v41i1.14700.


Clinical Manifestations and Management of Fibrotic Pulmonary Sarcoidosis.

Kim J, Gupta R J Clin Med. 2024; 13(1).

PMID: 38202248 PMC: 10780222. DOI: 10.3390/jcm13010241.


References
1.
Brooks D, Teyton L, Oldstone M, McGavern D . Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol. 2005; 79(16):10514-27. PMC: 1182641. DOI: 10.1128/JVI.79.16.10514-10527.2005. View

2.
Mescher M, Popescu F, Gerner M, Hammerbeck C, Curtsinger J . Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors. Semin Cancer Biol. 2007; 17(4):299-308. PMC: 2693139. DOI: 10.1016/j.semcancer.2007.06.008. View

3.
Malek T . The biology of interleukin-2. Annu Rev Immunol. 2007; 26:453-79. DOI: 10.1146/annurev.immunol.26.021607.090357. View

4.
Boulkroun S, Guenin-Mace L, Thoulouze M, Monot M, Merckx A, Langsley G . Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events. J Immunol. 2010; 184(3):1436-44. DOI: 10.4049/jimmunol.0902854. View

5.
Lee N, Barber L, Kanchwala A, Childs C, Kataria Y, Judson M . Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis. Clin Vaccine Immunol. 2010; 18(2):223-34. PMC: 3067365. DOI: 10.1128/CVI.00469-10. View